Analystreport

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) was downgraded by analysts at Jefferies Financial Group Inc. to a "sell" rating. They now have a $536.00 price targe

Regeneron Pharmaceuticals, Inc.  (REGN) 
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com